Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception

S I Makda; M J Davies; E Wilmot; J Bankart; T Yates; Harriet Fisher; A Anwar; K Khunti

doi:10.1111/dme.12051

Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception

S I Makda, M J Davies, E Wilmot, J Bankart, T Yates, Harriet Fisher, A Anwar, K Khunti

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

13 Citations (Scopus)

Abstract

AIMS: To describe the prescription of drugs either not recommended in pregnancy or potentially teratogenic, and contraception use by diabetes type in women of child-bearing age. METHODS: Retrospective, cross-sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre-existing diabetes. Independent sample t-test, Mann-Whitney test and χ(2) -test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. RESULTS: Four hundred and seventy eligible women were identified; the majority had a diagnosis of Type 2 diabetes (67%). Thirty-six per cent and 64% of women with Type 1 and Type 2 diabetes, respectively, were prescribed drugs not recommended for use in pregnancy (P

Original language	English
Journal	Diabetic Medicine
DOIs	https://doi.org/10.1111/dme.12051
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dme.12051

Handle.net

Persistent link

Cite this

@article{2961999e72884798bd61b9db83f45f75,

title = "Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception",

abstract = "AIMS: To describe the prescription of drugs either not recommended in pregnancy or potentially teratogenic, and contraception use by diabetes type in women of child-bearing age. METHODS: Retrospective, cross-sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre-existing diabetes. Independent sample t-test, Mann-Whitney test and χ(2) -test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. RESULTS: Four hundred and seventy eligible women were identified; the majority had a diagnosis of Type 2 diabetes (67%). Thirty-six per cent and 64% of women with Type 1 and Type 2 diabetes, respectively, were prescribed drugs not recommended for use in pregnancy (P ",

author = "Makda, {S I} and Davies, {M J} and E Wilmot and J Bankart and T Yates and Harriet Fisher and A Anwar and K Khunti",

note = "{\textcopyright} 2012 The Authors. Diabetic Medicine {\textcopyright} 2012 Diabetes UK.",

year = "2012",

doi = "10.1111/dme.12051",

language = "English",

journal = "Diabetic Medicine",

issn = "1464-5491",

publisher = "Wiley",

}

TY - JOUR

T1 - Prescribing in pregnancy for women with diabetes

T2 - use of potential teratogenic drugs and contraception

AU - Makda, S I

AU - Davies, M J

AU - Wilmot, E

AU - Bankart, J

AU - Yates, T

AU - Fisher, Harriet

AU - Anwar, A

AU - Khunti, K

PY - 2012

Y1 - 2012

N2 - AIMS: To describe the prescription of drugs either not recommended in pregnancy or potentially teratogenic, and contraception use by diabetes type in women of child-bearing age. METHODS: Retrospective, cross-sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre-existing diabetes. Independent sample t-test, Mann-Whitney test and χ(2) -test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. RESULTS: Four hundred and seventy eligible women were identified; the majority had a diagnosis of Type 2 diabetes (67%). Thirty-six per cent and 64% of women with Type 1 and Type 2 diabetes, respectively, were prescribed drugs not recommended for use in pregnancy (P

AB - AIMS: To describe the prescription of drugs either not recommended in pregnancy or potentially teratogenic, and contraception use by diabetes type in women of child-bearing age. METHODS: Retrospective, cross-sectional chart review undertaken in 22 general practices in Warwickshire, UK. Demographic, anthropometric, medical history, medication and contraception data were extracted from women aged 14 to 49 years with pre-existing diabetes. Independent sample t-test, Mann-Whitney test and χ(2) -test were used to test for univariable associations and multiple logistic regression was used to adjust for confounders. RESULTS: Four hundred and seventy eligible women were identified; the majority had a diagnosis of Type 2 diabetes (67%). Thirty-six per cent and 64% of women with Type 1 and Type 2 diabetes, respectively, were prescribed drugs not recommended for use in pregnancy (P

U2 - 10.1111/dme.12051

DO - 10.1111/dme.12051

M3 - Article (Academic Journal)

C2 - 23110381

SN - 1464-5491

JO - Diabetic Medicine

JF - Diabetic Medicine

ER -

Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception

Abstract

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this